或氧使用与听力障碍之间的关系:系统性审查和元分析
Maria Renata José1,2, Jéssica da Silva Ortega3, Jordana Batista Correia Baran2,4
1Department of Speech, Language and Hearing Sciences, São Paulo State University (UNESP), Marília, São Paulo, Brazil.
Journal of audiology & otology
|February 21, 2024
概括
这一系统性审查没有发现洛昆/氧洛昆使用与听力障碍之间存在显著的关联. 由于关于听觉系统副作用的证据确定性非常低,需要进行进一步的研究.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 基于证据的医学基于证据的医学.
背景情况:
- 氨基和氧氨基是用于疟疾和自身免疫性疾病的4-氨基氨基衍生物.
- 这些药物经常报告有听觉系统的副作用.
- 需要进行系统审查,以评估这些药物与听力障碍相关的证据.
研究的目的:
- 系统地审查和综合现有关于使用或基的患者听力障碍的文献.
- 评估使用这些4-氨基诺林衍生物与听力学变化之间的关联.
主要方法:
- 系统性审查包括观察和干预研究.
- 参与者使用洛昆/氧洛昆的听力评估数据.
- 使用统计数据元分析评估的方法质量:评估和审查工具.
- 使用GRADE工具评估的证据确定性.
主要成果:
- 17项研究被纳入了定性综合,其中5项研究被纳入了元分析.
- 没有发现听力障碍的统计学上显著的几率比率 (OR=0.76,95% CI=0.41-1.39).
- 在不同研究中观察到较低的异质性 (I2=0%).
结论:
- 目前的证据表明,洛昆/氧洛昆使用与听力障碍之间没有关联.
- 由于存在偏见,间接性和不准确性的风险,证据的确定性被评为非常低.
- 建议进一步进行高质量的研究来证实这些发现.
相关概念视频
Hazard Ratio
122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
122
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
137
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
137
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61


